Stock Markets May 14, 2026 04:17 PM

Breeze Acquisition Corp. II Raises $125 Million in NASDAQ IPO

Blank-check vehicle lists units on Nasdaq Global Market as it prepares to pursue tech-enabled targets across healthcare and advanced industries

By Ajmal Hussain BREZU

Breeze Acquisition Corp. II completed an initial public offering of 12.5 million units at $10.00 each, generating $125 million in gross proceeds. The units began trading on the Nasdaq Global Market on May 13, 2026. Each unit comprises one ordinary share and one right, with the rights convertible into fractional shares upon the closing of an initial business combination. The company, incorporated in the Cayman Islands, will direct its search toward companies with global operations and technology capabilities in healthcare, biotechnology, advanced manufacturing, robotics, artificial intelligence, and related sectors.

Breeze Acquisition Corp. II Raises $125 Million in NASDAQ IPO
BREZU

Key Points

  • Breeze Acquisition Corp. II sold 12.5 million units at $10.00 each, raising $125 million, and began trading on the Nasdaq Global Market on May 13, 2026 - markets impacted: capital markets, equity markets.
  • Each unit includes one ordinary share and one right; each right converts to one-fifth of one ordinary share upon completion of an initial business combination - markets impacted: securities structure and equity instruments.
  • The blank check company will target businesses with global operations and technology capabilities in healthcare, biotechnology, advanced manufacturing, robotics, and artificial intelligence - sectors impacted: healthcare, biotech, manufacturing, robotics, AI.

Breeze Acquisition Corp. II said it sold 12.5 million units at $10.00 apiece in an initial public offering, raising $125 million in gross proceeds. The units started trading on the Nasdaq Global Market on May 13, 2026, under the unit ticker BREZU.

Each unit issued in the offering consists of one ordinary share and one right. Under the terms disclosed, each right entitles the holder to receive one-fifth of one ordinary share upon the completion of an initial business combination. Following separation, the ordinary shares and the rights are expected to trade independently under the symbols "BREZ" and "BREZR," respectively.

The offering was led by IB Capital LLC and I-Bankers Securities, Inc., which served as the book-running managers. The Securities and Exchange Commission declared the registration statement effective on May 12, 2026, enabling the offering to proceed.

Breeze Acquisition Corp. II is a blank check company organized in the Cayman Islands. In its statement, the company identified a focused search area for potential targets: businesses with global operations and technology capabilities in healthcare, biotechnology, advanced manufacturing, robotics, artificial intelligence, and related sectors. The company intends to use the net proceeds from the offering to fund the activities associated with pursuing and completing a future business combination.

Legal counsel in the transaction included ArentFox Schiff LLP representing the company, while Allen Overy Shearman Sterling US LLP served as counsel to the underwriters. The net proceeds from the offering have been earmarked for the company’s future business combination activities.


What this means

  • The company now has capital reserved to pursue an initial business combination within the scope described, subject to the timing and terms of any transaction it may complete.
  • Holders of the units currently own a bundled interest - an ordinary share plus a right - with the mechanics of the rights tied explicitly to the closing of a business combination.
  • The separate trading of the ordinary shares and rights, if it occurs as anticipated, will create individual markets for each instrument under the anticipated tickers.

The information provided by the company outlines the structure of the offering and the stated industry focus, while the legal and underwriting teams responsible for the transaction are identified. The SEC's declaration of effectiveness on May 12, 2026, completed the regulatory step required to allow the offering to proceed and for the units to begin trading on May 13, 2026.

Risks

  • Completion of an initial business combination is a condition referenced in the rights' conversion mechanics, indicating uncertainty about whether and when a qualifying transaction will be completed - impacts healthcare, biotech, manufacturing, robotics, AI sectors.
  • The company will rely on the net proceeds from the offering to fund its future business combination activities, which creates exposure to the timing and sufficiency of those funds relative to transaction costs and market conditions - impacts capital markets and potential target sectors.
  • Ordinary shares and rights are expected to trade separately, which could introduce liquidity and pricing dynamics for each instrument as they begin independent trading - impacts equity trading and investor demand.

More from Stock Markets

MOEX Russia Index Ends Lower as Mining, Power and Oil & Gas Weigh on Market May 14, 2026 LVMH to Transfer Marc Jacobs Brand to WHP Global After Nearly Three Decades May 14, 2026 Gemini Space Station Shares Leap After $100 Million Bitcoin-Funded Investment May 14, 2026 After-hours movers: Applied Materials, Figma, DexCom, DLocal, StoneCo and Papa John’s react to earnings and strategic moves May 14, 2026 U.S. Equity Benchmarks Close Higher; Tech, Energy and Industrials Lead Gains May 14, 2026